CariGenetics Cancer Genetic Study Update
CariGenetics announced the “official update of its second major research initiative, the Caribbean Prostate Cancer Genetic Study.”
A spokesperson said, “CariGenetics is proud to announce the official update of its second major research initiative, the Caribbean Prostate Cancer Genetic Study, set to include 1,000 men across the Caribbean. Starting in Bermuda, this first-of-its-kind study see to deepen our understanding of the genetic factors contributing to prostate cancer and to pave the way for groundbreaking advancements in prevention, early detection, and treatment. As of the end of January 2025, the study has already surpassed significant milestone including hitting the 100-participant mark, which represents 10% of the recruitment goal, and officially launching in its second Caribbean island: Saint Lucia.
“The program has bee community-driven effort, with contributions and support from partners across Bermu including Prostate Awareness Bermuda, MASC and the DailyMale. Dr. Jonathan Makajuola, a leading figure in prostate cancer awareness, has been pivotal in these efforts, fur emphasizing the local impact of this initiative.”
“We’ve had an incredible response so far, with over 115 participants officially joining wit the first three months of recruitment,” said Dr. Carika Weldon, founder of CariGenetics. “This has been a collective effort—for the community, by the community – and we are seeing the power of unity in action.”
The spokesperson said, “By the time this study concludes, the team aims to recruit a total of 150 men from Bermuda. With the control group closed, the study is now focusing on recruiting men who have been diagnosed with prostate cancer or have a family history of cancer. The participation of these groups is vital to the study’s success.
“Key objectives of the study include:
- Understanding the hereditary risks associated with prostate cancer.
- Identifying genetic mutations specific to Caribbean population.
- Advancing personalized healthcare strategies for early detection and treatment.
- Identify genetic mutations and markers associated with prostate cancer risk and progression.
- Refine screening protocols based on genetic predisposition.
- Advance personalized treatment options through genetic insights.
“CariGenetics is calling on men across Bermuda to join the study. To conclude the study, CariGenetics is seeking men 18 and older with four Caribbean grandparents, including Bermuda, who have been diagnosed with prostate cancer or have a relative with any form of cancer. Your participation is essential to shaping the future of cancer research and care.”
“We are now working with faith-based community partners, like the Seven-Day Adventist Church, to ensure we reach every corner of the community. It may seem unconventional to discuss men’s health in January, but this is exactly what needs to happen to make sure our men are safe and informed,” added Dr. Weldon.
The spokesperson said, “This initiative highlights the importance of addressing prostate cancer in Caribbean populations, which are often disproportionately affected by the disease.”
John Payne, co-founder of Prostate Awareness Bermuda, said, “Genetic research is transforming the way we understand and combat prostate cancer. By identifying key genetic markers, we can improve early detection, develop more personalized treatments, and ultimately save lives. This initiative by CariGenetics is a vital step toward empowering men with the knowledge and resources they need to take control of their health and make informed decisions. The impact of this research extends beyond individual patients—it has the potential to revolutionize men’s healthcare globally.”
The spokesperson said, “To participate in the study in Bermuda, visit here or call 621-6303.”
Read More About
Category: All, technology
